- Home
- NTHI vs ELVA Comparison
NTHI vs ELVA Comparison
Compare NTHI & ELVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTHI
- ELVA
- Stock Information
- Founded
- NTHI 2008
- ELVA 1996
- Country
- NTHI United States
- ELVA Canada
- Employees
- NTHI N/A
- ELVA N/A
- Industry
- NTHI Biotechnology: Pharmaceutical Preparations
- ELVA
- Sector
- NTHI Health Care
- ELVA
- Exchange
- NTHI Nasdaq
- ELVA Nasdaq
- Market Cap
- NTHI 110.9M
- ELVA 125.5M
- IPO Year
- NTHI N/A
- ELVA N/A
- Fundamental
- Price
- NTHI $5.12
- ELVA $4.72
- Analyst Decision
- NTHI
- ELVA Strong Buy
- Analyst Count
- NTHI 0
- ELVA 4
- Target Price
- NTHI N/A
- ELVA $6.13
- AVG Volume (30 Days)
- NTHI 320.0K
- ELVA 273.0K
- Earning Date
- NTHI 01-01-0001
- ELVA 08-13-2025
- Dividend Yield
- NTHI N/A
- ELVA N/A
- EPS Growth
- NTHI N/A
- ELVA 61.27
- EPS
- NTHI N/A
- ELVA 0.03
- Revenue
- NTHI $79,990.00
- ELVA $54,875,000.00
- Revenue This Year
- NTHI N/A
- ELVA $46.69
- Revenue Next Year
- NTHI N/A
- ELVA $51.90
- P/E Ratio
- NTHI N/A
- ELVA $156.76
- Revenue Growth
- NTHI 13.52
- ELVA 10.88
- 52 Week Low
- NTHI $3.20
- ELVA $1.73
- 52 Week High
- NTHI $25.00
- ELVA $5.24
- Technical
- Relative Strength Index (RSI)
- NTHI N/A
- ELVA 56.97
- Support Level
- NTHI N/A
- ELVA $4.16
- Resistance Level
- NTHI N/A
- ELVA $5.24
- Average True Range (ATR)
- NTHI 0.00
- ELVA 0.36
- MACD
- NTHI 0.00
- ELVA -0.04
- Stochastic Oscillator
- NTHI 0.00
- ELVA 51.85
About NTHI NeOnc Technologies Holdings Inc. Common Stock
NeOnc Technologies Holdings Inc. is the developer of a novel molecular technology that provides enhanced targeted delivery of technologies for treating central nervous system diseases. The company product includes NEO100, which commenced Phase 2a clinical trials, which is used for treating glioblastoma, and has Orphan Drug and Fast Track designation from the United States Food and Drug Administration ("FDA").
About ELVA Electrovaya Inc.
Electrovaya Inc designs develop and manufacture proprietary lithium-ion batteries, battery systems, and battery-related products for energy storage, clean electric transportation and other specialized applications. It is a technology-focused company with extensive IP. The company generates revenue from the sale of batteries and battery systems. Business operations are segmented based on large format batteries and others. This technology offers enhanced safety and battery longevity. Geographically it earns key revenue from the United States.